A recent review' has suggested that reports of gold salts being inhibitory to adjuvant arthritis following parenteral administration may be explained by counterirritancy. While we cannot completely preclude this possibility, the following points seem relevant. The injection sites were examined daily and no signs of irritation or necrosis were observed, the animals were not distressed, and there were no adverse effects on bodyweight gain. NATM had no effect on the acute indomethacin-sensitive inflammation at day 3, but the secondary arthritis was inhibited in a dosedependent manner, with the activity being maintained for 14 days after cessation of dosing. Finally, the systemic noninflammatory disease was 
with fenclofenac.' Apart from the well known gastrointestinal adverse reactions of the non-steroidal anti-inflammatory drugs it has become increasingly apparent that these agents can cause a number of adverse renal effects, for example, acute renal failure, chronic renal damage, nephrotic syndrome and interstitial nephritis, and also abnormalities of water, sodium, and potassium homeostasis. 2 We would like to report our experience with a 66-yearold male patient suffering from rheumatoid arthritis for three years who was taking piroxicam for his arthritis and Moduretic for ankle oedema. As his arthritis was deteriorating piroxicam was stopped and instead he was started on diclofenac 50 mg three times a day and also penicillamine 125 mg a day. Before introduction of these drugs the laboratory investigations showed: white cell count 9-5x109/l, haemoglobin 10-9 g/dl, erythrocyte sedimentation rate 108 mm/h, serum urea 10-3 mmolUl, serum creatinine 96 ,mol/l, electrolytes and bicarbonate within normal limits. About 10 days later the patient complained of nausea and malaise and his urinary output fell to 500 ml in 24 hours. Investigations revealed normal urinary microscopy, no proteinuria, serum urea 22-3 mmol/l, serum creatinine 160 ,umol/l, and serum potassium 5-2 mmol/l, but the other electrolytes were within normal limits. A straight x-ray of the abdomen showed no abnormality of the renal outlines. Both penicillamine and diclofenac were stopped, after which the serum urea, creatinine, and potassium gradually fell and returned to normal levels in five days.
Our patient developed uraemia after only 10 days' treatment with diclofenac and penicillamine. Adverse reactions on the kidneys due to penicillamine are usually late events and appear initially with proteinuria.3 We cannot absolutely rule out penicillamine as the offending drug in our patient, but it seems unlikely. A more obvious suspect is diclofenac, as a number of non-steroidal anti-inflammatory drugs have now been reported to cause renal impairment believed due to inhibition of prostaglandins' action in the kidneys.2 In any patient who develops unexplained uraemia, especially in the presence of previous renal impairment or during the use of diuretics, a full drug history should be taken, and any non-steroidal anti-inflammatory drug should be withdrawn for a period to see if renal impairment improves, before resorting to further renal work up which may be necessary. Due caution should be exercised in prescribing these drugs to patients who may be liable to renal complications, in particular patients with chronic renal insufficiency, hepatic cirrhosis, cardiac failure, and intravascular volume contraction as a result of either nephrotic syndrome or the use of diuretics. 
